Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans
Cardiovascular Research · 2023
DOI: 10.1093/cvr/cvad153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2023. Verfasst von Simon Kraler und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, Zurich CH-8952, Switzerland. Hauptthemen laut MEDLINE: Growth Differentiation Factors, Heart Injuries, Myocardial Infarction. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Theodor Ida Herzog-Egli Stiftung, Swiss Heart Foundation.
Abstract (Originalsprache)
Aims
The heart rejuvenating effects of circulating growth differentiation factor 11 (GDF11), a transforming growth factor-β superfamily member that shares 90% homology with myostatin (MSTN), remains controversial. Here, we aimed to probe the role of GDF11 in acute myocardial infarction (MI), a frequent cause of heart failure and premature death during ageing. Methods and results In contrast to endogenous Mstn, myocardial Gdf11 declined during the course of ageing and was particularly reduced following ischaemia/reperfusion (I/R) injury, suggesting a therapeutic potential of GDF11 signalling in MI. Unexpectedly, boosting systemic Gdf11 by recombinant GDF11 delivery (0.1 mg/kg body weight over 30 days) prior to myocardial I/R augmented myocardial infarct size in C57BL/6 mice irrespective of their age, predominantly by accelerating pro-apoptotic signalling. While intrinsic cardioprotective signalling pathways remained unaffected by high circulating GDF11, targeted transcriptomics and immunomapping studies focusing on GDF11-associated downstream targets revealed attenuated Nkx2-5 expression confined to CD105-expressing cells, with pro-apoptotic activity, as assessed by caspase-3 levels, being particularly pronounced in adjacent cells, suggesting an indirect effect. By harnessing a highly specific and validated liquid chromatography-tandem mass spectrometry–based assay, we show that in prospectively recruited patients with MI circulating GDF11 but not MSTN levels incline with age. Moreover, GDF11 levels were particularly elevated in those at high risk for adverse outcomes following the acute event, with circulating GDF11 emerging as an independent predictor of myocardial infarct size, as estimated by standardized peak creatine kinase-MB levels.
Conclusion
Our data challenge the initially reported heart rejuvenating effects of circulating GDF11 and suggest that high levels of systemic GDF11 exacerbate myocardial injury in mice and humans alike. Persistently high GDF11 levels during ageing may contribute to the age-dependent loss of cardioprotective mechanisms and thus poor outcomes of elderly patients following acute MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, Zurich CH-8952, Switzerland.
- Laboratory of Cellular and Molecular Cardiology, Cardiocentro Ticino Institute, EOC, Lugano, Switzerland.
- Laboratories for Translational Research, EOC, Bellinzona, Switzerland.
- Department of Research and Education, University Hospital Zurich, Zurich, Switzerland.
- First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino Genova-Italian Cardiovascular Network, Genoa, Italy.
ORCID-Profile: Simon Kraler, Federico Carbone, Shalender Bhasin, Olivier Muller, Lorenz Räber, Fabrizio Montecucco, Thomas F Lüscher, Alexander Akhmedov
Förderung
- Swiss National Science Foundation
- Theodor Ida Herzog-Egli Stiftung
- Swiss Heart Foundation
- Foundation for Cardiovascular Research—Zurich Heart House
Zitieren
APA
Kraler, S., Balbi, C., Vdovenko, D., Lapikova-Bryhinska, T., Camici, G. G., Liberale, L., Bonetti, N., Canestro, C. D., Burger, F., Roth, A., Carbone, F., Vassalli, G., Mach, F., Bhasin, S., Wenzl, F. A., Muller, O., Räber, L., Matter, C. M., Montecucco, F., …, & Akhmedov, A. (2023). Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans. Cardiovascular Research. https://doi.org/10.1093/cvr/cvad153
Vancouver
Kraler S, Balbi C, Vdovenko D, Lapikova-Bryhinska T, Camici GG, Liberale L, et al. Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans. Cardiovascular Research. 2023. doi:10.1093/cvr/cvad153
BibTeX
@article{Kraler2023,
author = {Kraler, Simon and Balbi, Carolina and Vdovenko, Daria and Lapikova-Bryhinska, Tetiana and Camici, Giovanni G and Liberale, Luca and Bonetti, Nicole and Canestro, Candela Diaz and Burger, Fabienne and Roth, Aline and Carbone, Federico and Vassalli, Giuseppe and Mach, François and Bhasin, Shalender and Wenzl, Florian A and Muller, Olivier and Räber, Lorenz and Matter, Christian M and Montecucco, Fabrizio and Lüscher, Thomas F and Akhmedov, Alexander},
title = {Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans},
journal = {Cardiovascular Research},
year = {2023},
doi = {10.1093/cvr/cvad153}
}
EUVIMED